Arhgef15 Promotes Retinal Angiogenesis by Mediating VEGF-Induced Cdc42 Activation and Potentiating RhoJ Inactivation in Endothelial Cells

BACKGROUND: Drugs inhibiting vascular endothelial growth factor (VEGF) signaling are globally administered to suppress deregulated angiogenesis in a variety of eye diseases. However, anti-VEGF therapy potentially affects the normal functions of retinal neurons and glias which constitutively express...

Descripción completa

Detalles Bibliográficos
Autores principales: Kusuhara, Sentaro, Fukushima, Yoko, Fukuhara, Shigetomo, Jakt, Lars Martin, Okada, Mitsuhiro, Shimizu, Yuri, Hata, Masayuki, Nishida, Kohji, Negi, Akira, Hirashima, Masanori, Mochizuki, Naoki, Nishikawa, Shin-Ichi, Uemura, Akiyoshi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2012
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3448698/
https://www.ncbi.nlm.nih.gov/pubmed/23029280
http://dx.doi.org/10.1371/journal.pone.0045858

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3448698/
https://www.ncbi.nlm.nih.gov/pubmed/23029280
http://dx.doi.org/10.1371/journal.pone.0045858

Ejemplares similares